Answer
Aug 27, 2025 - 08:59 AM
Do you have the same question? Follow this Question
Aug 27, 2025 - 08:59 AM
We’ve provided several answers to questions related to Paxlovid (Nirmatrelvir/Ritonavir) , see some other helpful Q&A related to this product.
Question: What should be done if signs of a serious allergic reaction occur when taking Paxlovid?
Answer: If signs of a serious allergic reaction occur, such as difficulty breathing or swelling of the face, stop taking Paxlovid immediately and seek medical help. Prompt action can prevent severe health consequences.
Question: What should be considered before taking Paxlovid during pregnancy?
Answer: Paxlovid should be used during pregnancy only if the potential benefit justifies the risk. This consideration helps in weighing the benefits against potential risks to the fetus.
Question: What is the protein binding percentage of nirmatrelvir?
Answer: Nirmatrelvir has a protein binding of approximately 69%. Protein binding affects the drug's distribution and its free concentration in the bloodstream.
Question: What is the bioavailability of ritonavir?
Answer: The bioavailability of ritonavir is approximately 75%. High bioavailability means that a significant portion of the drug reaches systemic circulation, enhancing its therapeutic effect.
View all Paxlovid (Nirmatrelvir/Ritonavir) Questions & Answers